Signaling Pathways - MLK3 - Insulin and Insulin-like Receptors - IRAK - Sphingosine kinases (SphKs)
清除全部
-
B4877 URMC-099Target: MLK3Summary: MLK3抑制剂 -
B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂 -
B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A3505 IRAK-1-4 Inhibitor I3 CitationTarget: IRAKSummary: IRAK-1/4抑制剂 -
A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4抑制剂